希格生科

希格生科

希格生科

Biotech/Healthcare

Xige Biotech focuses on developing innovative small-molecule targeted cancer therapies and has assembled a world-leading R&D team. Its pipeline is designed to address the significant unmet need for targeted treatments for diffuse gastric cancer, potentially improving patient survival and creating…

Latest round: Series A (2026)

Source: ChinaBulls — chinabulls.com

Last updated 2026-01-01

Funding history

Request access to view this section.

Investors

Request access to view this section.

HQ & website

Request access to view this section.

Tags

Request access to view this section.